Post Graduate Institute of Medical Education and Research, Chandigarh, India.
All India Institute for Medical Sciences, Bilaspur, India.
Arch Orthop Trauma Surg. 2022 Jun;142(6):1239-1251. doi: 10.1007/s00402-021-03975-0. Epub 2021 Jun 6.
CLS Spotorno is a time-tested femoral stem design with excellent early results; the present review was designed to assess the published evidence on CLS Spotorno stem in the literature to evaluate its long-term outcomes and compare it to two other popular stem designs the uncemented Corail™ and the cemented Exeter™ stems.
Do CLS Spotorno stems provide adequate long-term rates of survival in terms of revisions and functional outcomes?
Medline, EMBASE and SCOPUS databases were searched for relevant articles and a total number of 670 hits were obtained, out of which 14 relevant studies were included in this review. Pooled analysis of revisions rates, subsidence and Harris Hip scores (HHS) were done.
All the 14 studies were retrospective in design but had sufficiently large follow-up periods (12.3-27 years, mean 17.1 years). Of the 2459 hips reviewed, the documented revision rate was only 6.2%, with aseptic loosening reported in 3.1% and subsidence > 2 mm in 2.6% cases. The overall survival was similar to reported smaller cohorts of Corail (95% at 12 years) and Exeter stems (100% at 17 years). Varus malposition was seen in 10.6% cases, but it did not show any influence on implant survival or revision rates. Distal pedestal formation was seen in 172 of 805 hips across seven studies, while distal cortical hypertrophy was seen in 70 cases out of 398 hips; these were not related with stem malposition. The overall functional outcome was good, with mean HHS of 88.65 (95% CI = 86.08-91.23, p < 0.01). The improvement in scores from preoperative values (of 43.9 points) were comparable to Corail (43.8) and Exeter (45) stems. Thigh pain was seen in only 41 cases out of 1097 hips.
Despite the limitations due to high heterogeneity of the cumulative data, the review suggests that CLS Spotorno femoral stems provides excellent long-term survival and good hip function. These outcomes are comparable to other commonly utilized femoral stems like the Corail and Exeter.
IV.
CLS Spotorno 是一种经过时间考验的股骨柄设计,具有出色的早期结果;本研究旨在评估文献中 CLS Spotorno 柄的已发表证据,以评估其长期结果,并将其与另外两种流行的柄设计(非骨水泥 Corail™和骨水泥 Exeter™)进行比较。
CLS Spotorno 柄在翻修率和功能结果方面提供足够的长期存活率吗?
在 Medline、EMBASE 和 SCOPUS 数据库中搜索相关文章,共获得 670 个命中结果,其中 14 项相关研究纳入本综述。对翻修率、下沉和 Harris 髋关节评分(HHS)进行了汇总分析。
所有 14 项研究均为回顾性设计,但随访时间足够长(12.3-27 年,平均 17.1 年)。在 2459 个髋关节中,记录的翻修率仅为 6.2%,其中 3.1%报告为无菌性松动,2.6%病例出现下沉>2mm。总体生存率与报道的较小 Corail 队列(12 年时为 95%)和 Exeter 柄(17 年时为 100%)相似。10.6%的病例出现内翻畸形,但它对植入物的存活率或翻修率没有影响。在 7 项研究的 805 个髋关节中,有 172 个出现远端墩形成,在 398 个髋关节中有 70 个出现远端皮质肥大;这些与柄位不正无关。总体功能结果良好,平均 HHS 为 88.65(95%CI=86.08-91.23,p<0.01)。与 Corail(43.8)和 Exeter(45)柄相比,术前评分(43.9 分)的改善情况相似。1097 个髋关节中有 41 个出现大腿疼痛。
尽管由于累积数据的高度异质性存在局限性,但该综述表明 CLS Spotorno 股骨柄可提供出色的长期存活率和良好的髋关节功能。这些结果与其他常用的股骨柄,如 Corail 和 Exeter,相当。
IV。